AbbVie (ABBV): analysis and statistics
Return, volatility, Sharpe ratio and risk for AbbVie, a component of the S&P 500 in the Health Care sector. Data as of 2026-09-13.
| Last close price | $257.12 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +23.74% |
| Total return over period | +88.67% |
| Annualized volatility | 24.74% |
| Period volatility | 42.71% |
| Sharpe ratio | 0.80 |
| Sortino ratio | 1.12 |
| Max drawdown | -20.74% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.70% |
| Correlation with the S&P 500 | 0.17 |
| Period range | $125.30 – $265.97 |
| Trading days analyzed | 751 |
Over the last 3.0 years, AbbVie (ABBV) has posted an annualized return of +23.74% with annual volatility of 24.74%, a Sharpe ratio of 0.80. Its worst stretch (max drawdown from a peak) was -20.74%. Its correlation with the S&P 500 is 0.17, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ABBV would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with ABBV →
Other Health Care stocks
Is it part of the S&P 500?
Yes, AbbVie (ABBV) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio